Success Metrics

Clinical Success Rate
88.3%

Based on 113 completed trials

Completion Rate
88%(113/128)
Active Trials
17(10%)
Results Posted
52%(59 trials)
Terminated
15(9%)

Phase Distribution

Ph not_applicable
42
25%
Ph phase_4
41
24%
Ph phase_2
32
19%
Ph phase_1
11
7%
Ph phase_3
33
20%
Ph early_phase_1
5
3%

Phase Distribution

16

Early Stage

32

Mid Stage

74

Late Stage

Phase Distribution164 total trials
Early Phase 1First-in-human
5(3.0%)
Phase 1Safety & dosage
11(6.7%)
Phase 2Efficacy & side effects
32(19.5%)
Phase 3Large-scale testing
33(20.1%)
Phase 4Post-market surveillance
41(25.0%)
N/ANon-phased studies
42(25.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.3%

113 of 134 finished

Non-Completion Rate

15.7%

21 ended early

Currently Active

17

trials recruiting

Total Trials

169

all time

Status Distribution
Active(21)
Completed(113)
Terminated(21)
Other(14)

Detailed Status

Completed113
Terminated15
Recruiting15
unknown14
Withdrawn6
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
169
Active
17
Success Rate
88.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (3.0%)
Phase 111 (6.7%)
Phase 232 (19.5%)
Phase 333 (20.1%)
Phase 441 (25.0%)
N/A42 (25.6%)

Trials by Status

active_not_recruiting21%
terminated159%
unknown148%
not_yet_recruiting42%
recruiting159%
completed11367%
withdrawn64%

Recent Activity

Clinical Trials (169)

Showing 20 of 169 trialsScroll for more
NCT00018057Phase 2

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Recruiting
NCT06860958Phase 3

Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Recruiting
NCT04850222Phase 2

Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma

Completed
NCT06046859Phase 4

Can Immediate Post-injury Fluoxetine Improve the Recovery Trajectories of Victims in Bodily Trauma?

Recruiting
NCT06898606Phase 1

Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression

Recruiting
NCT07478796Phase 4

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

Recruiting
NCT07456501Not Applicable

Fluoxetine and Understanding Social Experiences

Not Yet Recruiting
NCT07424781Not Applicable

Fluoxetine on Emotional Experience (FLEX) Study

Recruiting
NCT05041907Phase 2

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Recruiting
NCT05814640Phase 1

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

Recruiting
NCT07007221Phase 2

Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV

Not Yet Recruiting
NCT03466346Not Applicable

SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project

Completed
NCT07239011Phase 1

Dapagliflozin in Depression

Recruiting
NCT06384209Not Applicable

The Friendship Bench Plus Trial

Recruiting
NCT01672255Early Phase 1

Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)

Completed
NCT03228732Early Phase 1

The Effects of Fluoxetine and/or DHEA

Recruiting
NCT02751632Phase 3

The Staged Treatment in Early Psychosis Study

Completed
NCT05634707Early Phase 1

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Active Not Recruiting
NCT04899687Phase 2

Study of Dextromethorphan in OCD and Related Disorders

Recruiting
NCT07115472Not Applicable

Fluoxetine in Refractory Superior Mesenteric Artery Syndrome by Targeting Comorbid Somatic Symptom Disorder

Completed

Drug Details

Intervention Type
DRUG
Total Trials
169